Medical Device Network on MSN2h
Artera partners with Tempus to expand AI cancer test accessArtera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...
A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...
It’s tough for a man to know what to do following a diagnosis of prostate cancer.The treatment is often worse than the ...
David James, director of patient projects and influencing at Prostate Cancer Research, has set the record straight on some of ...
The FDA has granted a 510 (k) clearance to the Ibex Prostate Detect software (formerly Galen Second Read). The Ibex Prostate ...
WYFF 4 Greenville-Spartanburg on MSN2d
WYFF News 4's Nigel Robertson shares his journey after cancer diagnosisWYFF News 4's Nigel Robertson has spent more than two decades at WYFF and recently shared his cancer journey after a ...
In the next in our series, GP Dr Roger Henderson debunks common myths about prostate cancer – and highlights some less ...
Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...
News Medical on MSN1d
Globally prostate and testicular cancer rates climb, but mortality is fallingNew research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...
The number of cancer diagnoses in the Netherlands increased again last year, rising by 3,000 to around 130,000 people finding ...
TUESDAY, Feb. 4, 2025 (HealthDay News) -- It’s tough for a man to know what to do following a diagnosis of prostate cancer. The treatment is often worse than the risk posed by the cancer itself ...
Prostate cancer is often seen as an unavoidable part of ageing, especially among men, but there are many myths that can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback